Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Earnings Preview For Nov 3 - 7 - Earnings Preview
Oct 31, 2008 10:03 PM
- Analyst Comments: Newfield E&P, Genomic Health, NCI Building, Crocs, FTI Consulting
Aug 11, 2008 06:57 PM
- Analyst Comments: CarMax, ArvinMeritor, Avnet, Genomic Health, MGIC Investment, Cooper Tire, General Motors
Jun 12, 2008 01:52 PM
- Analyst Comments: Genomic Health, Diageo, NVIDIA, Santarus
May 09, 2008 05:19 PM
- Analyst Comments: Sealed Air, Genomic Health, Journal Communications, Celanese, DST Systems, Net Servicos, Canadian National, Equifax
Apr 23, 2008 03:44 PM
- Analyst Comments: Genomic , Volcom, Carnival, Newcastle Investment, PepsiAmericas
Dec 26, 2007 04:31 PM
- Sequenom (NASDAQ:SQNM): Target upped to $15 at OpCo
Oct 15, 2007 12:22 PM
- Genomic Health's Pipeline Thin
Oct 08, 2007 04:25 PM
- Genomic Health Announces Multiple Posters to Be Presented at American Society of Clinical Oncology Annual Meeting and CapMed Awarded First Honors for Personal Health Record Systems at 2006 TEPR Awards
Jun 02, 2006 12:01 PM
- Genomic Health to Present at Stephens Fall Investment Conference
Nov 11, 2008 08:03 AM
- Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated
Nov 10, 2008 08:02 AM
- Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
Nov 05, 2008 04:05 PM
- Genomic Health to Announce Third Quarter 2008 Financial Results and Host Conference Call on Wednesday, November 5, 2008
Oct 29, 2008 08:02 AM
- Wall Street Media Presents Exclusive Videos from the JMP Healthcare Focus Conference
Oct 08, 2008 03:01 PM
- Genomic Health to Present at JMP Securities Healthcare Focus Conference
Sep 30, 2008 08:02 AM
- Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients
Sep 06, 2008 02:00 PM
- Genomic Health Announces Publication of a Study Comparing Oncotype DX(R) and Adjuvant! Online in Node-Negative and Node-Positive Hormone Receptor-Positive Breast Cancer Patients
Sep 03, 2008 08:31 AM
- Zacks Bull and Bear of the Day Highlights: Vale Do Rio Doce, Deckers Outdoor, Barclays, Genomic Health and Newfield Exploration
Aug 12, 2008 01:08 AM
- Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress
Aug 05, 2008 04:02 PM
- Form 4 GENOMIC HEALTH INC For: Nov 12 Filed by: Baker Joffre (10K)
Nov 13, 2008 08:45 PM
- Form 4 GENOMIC HEALTH INC For: Nov 10 Filed by: Cole G Bradley (10K)
Nov 12, 2008 06:17 PM
- Form 4 GENOMIC HEALTH INC For: Nov 10 Filed by: Scott Randal W (10K)
Nov 12, 2008 06:14 PM
- Form 4 GENOMIC HEALTH INC For: Oct 13 Filed by: Scott Randal W (10K)
Oct 15, 2008 08:38 PM
- Form 4 GENOMIC HEALTH INC For: Sep 30 Filed by: Baker Joffre (10K)
Oct 02, 2008 11:15 PM
- Form 4 GENOMIC HEALTH INC For: Sep 24 Filed by: Shak Steven (10K)
Sep 26, 2008 08:30 PM
- Form 4 Scott Randal W For: Sep 15 (10K)
Sep 17, 2008 07:18 PM
- Form 4 Shak Steven For: Aug 26 (10K)
Aug 26, 2008 10:15 PM
- Form 4 Baker Joffre For: Aug 26 (10K)
Aug 26, 2008 10:12 PM
- Form 4 GENOMIC HEALTH INC For: Aug 18 Filed by: Cole G Bradley (10K)
Aug 19, 2008 08:26 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
GHDX
|
Compare to S&P
|
| YTD |
-23.28 %
|
-0.01 %
|
| 4 Weeks |
-10.46 %
|
-2.03 %
|
| 12 Weeks |
-23.65 %
|
8.03 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 26.67 %
|
|
EPS Growth in Last Year: 57.69 %
|
|
Sales Growth in Last Quarter: 1.22 %
|
|
Sales Growth in Last Quarter: 76.85 %
|
|
|
